Biotechnology

Filter

Current filters:

None

Popular Filters

74 to 98 of 2384 results

Biotherapies could save millions of euros when treating auto-immune diseases

Biotherapies could save millions of euros when treating auto-immune diseases

08-10-2014

Health care providers could save millions of euros if biotherapies were used in the treatment of Crohn’s…

Anti-Arthritics/RheumaticsBiotechnologyEuropeFinancialHealthcareResearchTheradiag

Cardio3 Biosciences gains preferred access to all Mayo Clinic regenerative medicine portfolio

Cardio3 Biosciences gains preferred access to all Mayo Clinic regenerative medicine portfolio

08-10-2014

Belgium biotech firm Cardio3 BioSciences says it has signed a preferred access agreement with the USA’s…

BelgiumBiotechnologyC-CureCardio-vascularCardio3 BioSciencesResearchUSA

US FDA grants Fast Track status to BrainStorm Cell Therapeutics for ALS treatment NurOwn

US FDA grants Fast Track status to BrainStorm Cell Therapeutics for ALS treatment NurOwn

07-10-2014

The US Food and Drug Administration has designated a product from stem cell treatment developer BrainStorm…

BiotechnologyBrainStorm Cell TherapeuticsNeurologicalNurOwnRegulationUSA

Merck Serono links with ICR and Wellcome Trust on anti-cancer drugs

Merck Serono links with ICR and Wellcome Trust on anti-cancer drugs

07-10-2014

German life sciences major Merck KGaA says its biopharma division Merck Serono has entered into a co-development…

BiotechnologyGermanyLicensingMerck KGaAMerck SeronoOncologyResearch

Regeneron gains further FDA indications for Eylea

Regeneron gains further FDA indications for Eylea

07-10-2014

The US Food and Drug Administration has approved biotech firm Regeneron Pharmaceuticals’ Eylea (aflibercept)…

BayerBiotechnologyEyleaOphthalmicsRegeneron PharmaceuticalsRegulationUSA

CleveXel Pharma licenses two new oncology patents from SATT Sud Est

CleveXel Pharma licenses two new oncology patents from SATT Sud Est

06-10-2014

French company CleveXel Pharma has been granted a license by the SATT Sud Est, a technology transfer…

BiotechnologyCleveXel PharmaFranceLicensingOncologyPatentsSATT Sud Est

PDL BioPharma appoints Danny Hart as vice president of business development

PDL BioPharma appoints Danny Hart as vice president of business development

06-10-2014

PDL BioPharma has appointed Danny Hart as vice president of business development.

BiotechnologyBoardroomDanny HartPDL BioPharmaUSA

Clear conditions for biosimilars the best way to boost patient safety says Danish Pharmaceutical Association

Clear conditions for biosimilars the best way to boost patient safety says Danish Pharmaceutical Association

06-10-2014

When treating patients, patient safety is crucial. Regardless of whether this concerns biological, biosimilar…

BiosimilarsBiotechnologyDenmarkPharmacologyRegulation

AfriCoLeish launches Phase III study on Gilead's AmBisome in treatment of visceral leishmaniasis

AfriCoLeish launches Phase III study on Gilead's AmBisome in treatment of visceral leishmaniasis

06-10-2014

AfriCoLeish, the international research and development consortium formed by six research organizations…

AfriCoLeishAmbisomeAnti-viralsBiotechnologyEthiopiaGilead SciencesResearch

Yale's Stephen Waxman to collaborate with Convergence Pharmaceuticals on chronic pain

Yale's Stephen Waxman to collaborate with Convergence Pharmaceuticals on chronic pain

06-10-2014

Convergence Pharmaceuticals Holdings, focused on developing analgesic medicines, is to collaborate with…

AnalgesiaBiotechnologyConvergence PharmaceuticalsResearchUK

Orphan status for Horizon Pharma’s Actimmune in Friedreich's ataxia

Orphan status for Horizon Pharma’s Actimmune in Friedreich's ataxia

04-10-2014

The US Food and Drug Administration has granted orphan drug designation for Ireland-headquartered specialty…

ActimmuneBiotechnologyHorizon PharmaRare diseasesRegulationUSA

Prima BioMed to acquire Immutep for $28 million

Prima BioMed to acquire Immutep for $28 million

03-10-2014

France-based Immutep, a late-stage private biopharmaceutical company in the rapidly growing field of…

BiotechnologyFranceImmunologicalsImmutepMergers & AcquisitionsOncologyPrima BioMed

Sigma-Aldrich acquires Cell Marque to grow antibody portfolio

Sigma-Aldrich acquires Cell Marque to grow antibody portfolio

03-10-2014

USA-based life sciences company Sigma-Aldrich has entered into an agreement to acquire US antibody company…

AnatomyBiologyBiotechnologyImmunologicalsMergers & AcquisitionsProtein methodsSigma-AldrichUSA

Incyte earns $60 million milestone on European reimbursement for Jakavi

Incyte earns $60 million milestone on European reimbursement for Jakavi

02-10-2014

US biopharma company Incyte says that it has earned a $60 million milestone payment from Swiss pharma…

BiotechnologyEuropeFinancialIncyteJakafiJakaviNovartisOncologyPricing

Denmark’s Forward Pharma plans IPO

Denmark’s Forward Pharma plans IPO

02-10-2014

Denmark-based Forward Pharma A/S today announced it has commenced an underwritten initial public offering…

BiotechnologyDenmarkFinancialForward PharmaImmunologicals

Oxford BioTherapeutics and Berlin Chemie/Menarini update on $1 billion oncology investment alliance

Oxford BioTherapeutics and Berlin Chemie/Menarini update on $1 billion oncology investment alliance

02-10-2014

UK biotech firm Oxford BioTherapeutics and family-owned Italian Berlin Chemie/Menarini Group have designated…

BiotechnologyItalyMenariniOncologyOxford BioTherapeuticsResearchUK

WuXi PharmaTech acquires XenoBiotic Labs

WuXi PharmaTech acquires XenoBiotic Labs

01-10-2014

Chinese pharma, biotech and devices firm WuXi PharmaTech says it has acquired XenoBiotic Laboratories,…

BiotechnologyChinaMergers & AcquisitionsWuXi PharmaTech

Eurofins Genomics expands business into Italy

Eurofins Genomics expands business into Italy

01-10-2014

Eurofins Genomics, the genomics division of Eurofins Scientific Group, has expanded its business into…

BiotechnologyEurofins GenomicsGeneticsItalyMarkets & Marketing

ESMO 2014: Merck's Keytruda and B-MS' Opdivo

ESMO 2014: Merck's Keytruda and B-MS' Opdivo

30-09-2014

Early results from pharma giant Merck & Co on the use of its Keytruda (pembrolizumab) in patients with…

BiotechnologyBristol-Myers SquibbKeytrudaMerck & CoMerck Research LaboratoriesOncologyOpdivoResearchSpain

Avacta Life Sciences invests $16.2 million in Affimers as engineered alternative to antibodies

Avacta Life Sciences invests $16.2 million in Affimers as engineered alternative to antibodies

30-09-2014

Avacta Life Sciences, a division of Avacta Group is investing £10 million ($16.2 million) in the launch…

AvactaBiotechnologyResearchUK

NeoGenomics appoints Robert Shovlin as chief operating officer

NeoGenomics appoints Robert Shovlin as chief operating officer

30-09-2014

Cancer-focused genetic testing service provider NeoGenomics has appointed Robert Shovlin as chief operating…

BiotechnologyBoardroomNeoGenomicsOncologyUSA

Biosimilars set to revolutionize global drug development industry, says report

Biosimilars set to revolutionize global drug development industry, says report

30-09-2014

Intellectual Property and Science business of Thomson Reuters today announced the release of Biosimilars:…

BiosimilarsBiotechnologyGlobalMarkets & MarketingResearch

Karolinska Development appoints Klaus Wilgenbus as interim chief executive

Karolinska Development appoints Klaus Wilgenbus as interim chief executive

30-09-2014

Swedish drug developer Karolinska Development has appointed current board member Klaus Wilgenbus as chief…

BiotechnologyBoardroomKarolinska DevelopmentKlaus WilgenbusSweden

74 to 98 of 2384 results

Parexel

Parexel

Back to top